PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) 3-Year EBITDA Growth Rate : 0.30% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk 3-Year EBITDA Growth Rate?

PT Industri Jamu dan Farmasi Sido Muncul Tbk's EBITDA per Share for the three months ended in Mar. 2024 was Rp16.87.

During the past 12 months, PT Industri Jamu dan Farmasi Sido Muncul Tbk's average EBITDA Per Share Growth Rate was -5.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 0.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Industri Jamu dan Farmasi Sido Muncul Tbk was 22.90% per year. The lowest was -1.10% per year. And the median was 9.60% per year.

Competitive Comparison of PT Industri Jamu dan Farmasi Sido Muncul Tbk's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, PT Industri Jamu dan Farmasi Sido Muncul Tbk's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Industri Jamu dan Farmasi Sido Muncul Tbk's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Industri Jamu dan Farmasi Sido Muncul Tbk's 3-Year EBITDA Growth Rate falls into.

PT Industri Jamu dan Farmasi Sido Muncul Tbk 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PT Industri Jamu dan Farmasi Sido Muncul Tbk 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Industri Jamu dan Farmasi Sido Muncul Tbk's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Gajahmada No. 123, 1st Floor, Gedung Hotel Tentrem, Office Sido Muncul, Lantai 1, Semarang, IDN, 50134

Website

https://www.sidomuncul.co.id

PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Headlines

No Headlines